Latest New Zealand News

Biome Australia’s Activated Probiotics brand surpasses one million boxes sold in Australia, approaches top pharmacy ranking, and launches nationally in Canada, setting the stage for FY26 profitability.

New Age Exploration (ASX: NAE) has confirmed high-grade gold mineralisation consistent with Hemi-style intrusion at its Wagyu Gold Project in Western Australia, while also expanding its footprint through the acquisition of the Wallah Silver Project in NSW and progressing drilling in New Zealand.

Algorae Pharmaceuticals has struck an exclusive commercial and licensing agreement with global pharma Zydus Lifesciences to bring 10 injectable, oral, and specialty medicines to Australia and New Zealand, pending regulatory approvals.

ECS Botanics reports a third straight quarter of positive operating cash flow, driven by strong B2C growth and strategic international shipments to Germany and New Zealand.

Santana Minerals advanced its Bendigo-Ophir Gold Project in New Zealand with a confirmed consent decision date, major equipment agreements, and a substantial capital raise, setting the stage for development.

Barramundi Limited’s portfolio took a heavy hit in Q1 2026, with a 15.4% adjusted NAV decline amid AI disruption anxieties and geopolitical tensions. The fund responded by trimming tech holdings and adding miners BHP and Rio Tinto, betting on copper demand and scale advantages.

Kingfish Limited’s portfolio endured a tough first quarter of 2026, with a 7.2% adjusted NAV decline amid Iran conflict-driven volatility. While a2 Milk’s expansion in China buoyed gains, shares in consumer-exposed names and tech-linked Vista Group plunged sharply.

MFF Capital Investments has updated its dividend distribution details for the half-year ending December 2025, confirming a fully franked 10-cent dividend payable in May and setting reinvestment plan prices at AUD 4.577.

The Federal Court has imposed a $1.55 million penalty on Money3 Loans, a Solvar subsidiary, for limited breaches of the National Consumer Credit Act between 2019 and 2021. Solvar highlights strengthened governance and underwriting since the period in question.

Beetaloo Energy has launched a $5 million Share Purchase Plan at $0.28 per share, following a $66.3 million institutional placement at the same price. The SPP aims to fund ongoing development activities ahead of first gas production in late 2026.

Greenvale Energy has sharpened its uranium exploration focus with new step-out targets at Oasis and secured a critical exploration licence at Douglas River, while pushing its Alpha Project into product development.

Fat Prophets Global Contrarian Fund (ASX: FPC) is raising up to $8.45 million through a pro-rata rights issue priced at a premium, offering one option per new share. The issue is partly underwritten and sees directors committing to full participation.